Aging
Navigate
Editorial|Volume 12, Issue 21|pp 20931—20933

OPA1, a new mitochondrial target in cancer therapy

Stephanie Herkenne1,2,3, Luca Scorrano1,2
  • 1Department of Biology, University of Padova, Padova, Italy
  • 2Veneto Institute of Molecular Medicine, Padova, Italy
  • 3Interdisciplinary Cluster in Applied Genoproteomics (GIGA) Research Center, University of Liège, Liège, Belgium
Received: September 27, 2020Accepted: October 5, 2020Published: November 13, 2020

Copyright: © 2020 Herkenne and Scorrano. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.